{"slideshow_credits": null, "snippet": "A daily pill of the drug isoniazid can often fend off fatal tuberculosis in people with H.I.V., according to a large new study.", "abstract": "Study in journal Lancet Infectious Disease shows that daily dose of isoniazid, a generic antibiotic, can often fend off lethal bouts of tuberculosis in people with HIV.", "section_name": "Health", "print_page": "5", "document_type": "article", "byline": {"person": [{"lastname": "McNEIL", "qualifier": "Jr", "rank": 1, "firstname": "Donald", "role": "reported", "organization": "", "middlename": "G."}], "original": "By DONALD G. McNEIL Jr", "contributor": ""}, "web_url": "http://www.nytimes.com/2013/08/20/health/pill-can-prevent-fatal-tb-in-hiv-patients.html", "lead_paragraph": "A daily pill of the drug isoniazid can often fend off fatal tuberculosis in people with H.I.V., according to a large new study.", "headline": {"main": "Pill Can Prevent Fatal TB in H.I.V. Patients", "content_kicker": "Global Health", "print_headline": "Pill Can Prevent Fatal TB in H.I.V. Patients"}, "_id": "5220a89538f0d8740ac9ad0b", "word_count": "259", "multimedia": [], "pub_date": "2013-08-20T00:00:00Z", "source": "The New York Times", "news_desk": "Science", "keywords": [{"name": "subject", "value": "Tuberculosis", "is_major": "Y", "rank": "1"}, {"name": "subject", "value": "Acquired Immune Deficiency Syndrome", "is_major": "Y", "rank": "2"}, {"name": "organizations", "value": "Lancet Infectious Diseases, The (Journal)", "is_major": "Y", "rank": "3"}, {"name": "subject", "value": "Antibiotics", "is_major": "Y", "rank": "4"}], "blog": [], "subsection_name": null, "type_of_material": "News"}